News & Perspective

Dec 22, 2008

Dec 22, 2008

FDA approves shortened anthrax-vaccine course

(CIDRAP News) – The US Food and Drug Administration (FDA) recently approved a new version of BioThrax—the nation's only licensed anthrax vaccine—that requires fewer doses and changes the injection route.

Dec 22, 2008

Dec 22, 2008

EU panel supports innovative pandemic, seasonal flu vaccines

(CIDRAP News) – An H5N1 influenza vaccine made by Baxter International could become the first cell culture–based H5N1 influenza vaccine to be approved for marketing, following its endorsement by a committee of the European Medicines Agency (EMEA) last week.

Recommendations of the Committee for Medicinal Products for Human Use (CHMP) are usually followed by the EMEA within a few months.